Helaina Raises $20 Million in Series A to Scale Production of its Human Milk Proteins Using Precision Fermentation Co-Led by Spark Capital and Siam Capital

Helaina, the company using precision fermentation to recreate immune-equivalent proteins previously only available in breast milk, announced today it has raised $20 million in Series A funding. The round was co-led by Spark Capital and Siam Capital, with additional investment…